SHPGF

 
Ordinary Shares SEC Reporting - Current
OTC Pink Current Information
Contact Info
  • 5 Riverwalk
  • Citywest Business Campus
  • Dublin 24
  • Ireland

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000936402
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Angus Russell CEO, CFO
Graham Hetherington CFO
N.C. Harris Secretary
Tatjana May Legal Counsel
Company Directors
Susan Kilsby Non-Executive Director
Olivier Bohuon Non-Executive Director
Company Notes
  • Formerly=Shire Ltd. until 10-2008
  • Formerly=Shire plc until 5-2008
  • Formerly=Shire Pharmaceuticals Group Plc until 11-05
Service Providers
Accounting/Auditing Firm
Deloitte LLP
2 New Street Square
London, EC4A 3BZ
United Kingdom

Legal Counsel
Not Available
Investor Relations Firm
Not Available
SHPGF Security Details Other Company Securities
Share Structure
Market Value1 $32,874,389,365 a/o Dec 05, 2016
Authorized Shares Not Available
Outstanding Shares 562,532,330 a/o Apr 27, 2012
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record 54 a/o Feb 23, 2012
Non US Stock Exchange Listing
SHP - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 21,730 (387.77%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security